2005•Unpublished venueRequires access

Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.

Thomas J. Smith, James Khatcheressian

Open publisher page 401 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 401 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hormonal therapy, Medicine, Cancer, Breast cancer, Chemotherapy, Oncology, Internal medicine, Hormone

Back to paper search Browse research topics Original source

Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717. — Research Paper | ScholarLens